Delivery Order SPE2DB25D3202-SPE2DB25FTBGP
Award Date 9/3/25
Potential Completion Date 9/4/25
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,909.37 delivery order to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (unit dose, 10 count packages) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price contract represents a non-competitive, non-set-aside award and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. UBRELVY (ubrogepant) is an acute migraine treatment medication, reflecting the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a $13,431.90 delivery order to AmerisourceBergen Drug Corp for UBRELVY (ubrogepant) 100 mg tablets in unit dose packaging of 10 tablets on April 24, 2025, with completion targeted for April 25, 2025. This competitively awarded, non-set-aside contract represents a firm fixed-price transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $2,875.81 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (100 unit dose packages of 10 tablets each) on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order represents a non-competitive set-aside purchase and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. UBRELVY (ubrogepant) is a calcitonin gene-related peptide...
- The Defense Logistics Agency awarded a $5,423.70 delivery order to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (10-unit dose packages) with a completion deadline of September 2, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's corporate...
- The Defense Logistics Agency awarded a $9,639.92 delivery order to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (unit dose, 10s) on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. UBRELVY (ubrogepant) is a calcitonin gene-related peptide receptor antagonist used for acute...
- The Defense Logistics Agency awarded a delivery order valued at $4,164.75 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablet unit dose packages on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. UBRELVY (ubrogepant) is a calcitonin gene-related peptide receptor antagonist used...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for UBRELVY (Ubrogepant) 100 mg tablets, unit dose packages of 10, valued at $1,158.25 with a firm fixed price structure. This award, issued on July 21, 2025, represents a non-set-aside competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the contractor's distribution facility in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,514.77 for UBRELVY 50 mg tablets (UD 10s) on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. UBRELVY (ubrogepant) is an acute migraine treatment medication, representing one of numerous pharmaceutical products supplied...
- The Defense Logistics Agency awarded a delivery order valued at $13,759.20 to AmerisourceBergen Drug Corp for the supply of UBRELVY (ubrogepant) 100 mg tablets in unit-dose packaging on September 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 17, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. UBRELVY is a migraine treatment medication,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of UBRELVY (ubrogepant) 50 mg tablets in unit dose packaging of 10 tablets each, with a ceiling value of $3,085.51. This is a firm fixed price delivery order with an ultimate completion date of May 28, 2025, executed under a competitive, non-set-aside procurement process. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...